The European Union's pharmaceutical sector is in a perpetual state of transformation. With rigorous regulations, expanding patient demands, and the rapid pace of research, navigating this complex landscape requires a prudent approach. Pharmaceutical companies must adjust to this shifts by integrating innovative technologies, working with key stakeh